FIELD: medicine.
SUBSTANCE: method involves patient's blood analysis on the first day following ST elevation myocardial infarction for insulinemia, glycemia, free fatty acids (FFAs), retinol-binding protein, tumour necrosis factor and ghrelin; the measured values are used to calculate linear classification discriminator function (LCDF1-c) by formula: LCDF1-c=-3.877+0.095Adp+0.246Grl-0.025IL-6-0.053TNF, wherein ADP is the adiponectin concentration, Grl is the ghrelin level, IL-6 is the interleukin 6 concentration, while TNF is tumour necrosis factor, a probable risk of insulin resistance is stated if LSDF1 is less than a cluster separation point of 0.4545 and approaching a centroid line of -0.561 as close as possible.
EFFECT: more reliable early hospital diagnosis of potential insulin resistance in the patients suffered ST elevation myocardial infarction.
2 ex, 2 dwg, 2 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREDICTION OF EARLY POST-INFARCTION ANGINA IN PATIENTS WITH ACUTE ST-ELEVATION MYOCARDIAL INFARCTION ACROSS STAYING IN HOSPITAL | 2014 |
|
RU2543356C1 |
METHOD OF PREDICTING ACUTE LEFT VENTRICULAR FAILURE IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION WITH ST SEGMENT ELEVATION OF THE ANTERIOR WALL OF THE LEFT VENTRICLE | 2023 |
|
RU2800404C1 |
METHOD FOR DETERMINING THE PROBABILITY OF OCCURRENCE OF A HOSPITAL ADVERSE EVENT AFTER CORONARY BYPASS SURGERY | 2021 |
|
RU2770819C1 |
METHOD FOR REVASCULARISATION OF MULTIPLE CORONARY BED LESION ACCOMPANYING ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION | 2013 |
|
RU2544096C1 |
METHOD FOR PREDICTING ADVERSE OUTCOMES UP TO 12 MONTHS IN PATIENTS WITH ACUTE CORONARY SYNDROME | 2020 |
|
RU2747693C1 |
METHOD FOR DETERMINING THE RISK OF MYOCARDIAL INFARCTION WITH ST SEGMENT ELEVATION USING GENETIC MARKERS | 2019 |
|
RU2711623C1 |
METHOD FOR PREDICTION OF LETHAL OUTCOME IN PATIENTS WITH CARDIOGENIC SHOCK IN PERCUTANEOUS CORONARY INTERVENTION | 2015 |
|
RU2580164C1 |
METHOD FOR PREDICTION OF PROBABILITY OF DEVELOPING ACUTE CARDIA ANEURISM | 2011 |
|
RU2469638C1 |
METHOD FOR PREDICTION OF PROGRESSION OF CARDIOVASCULAR COMPLICATIONS OF ACUTE CORONARY SYNDROME WITH ST-SEGMENT ELEVATION | 2014 |
|
RU2567031C1 |
METHOD OF DIAGNOSING GENETIC PREDISPOSITION TO DEVELOPMENT OF PHENOMENON OF CORONARY MICROVASCULAR OBSTRUCTION DURING PERCUTANEOUS CORONARY INTERVENTIONS IN PATIENTS WITH MYOCARDIAL INFARCTION WITH ST SEGMENT ELEVATION | 2023 |
|
RU2811933C1 |
Authors
Dates
2015-04-27—Published
2013-12-18—Filed